M&A Deal Summary |
|
|---|---|
| Date | 2021-06-30 |
| Target | Orgentec |
| Sector | Life Science |
| Buyer(s) | Sebia |
| Sellers(s) | Water Street Healthcare Partners |
| Deal Type | Add-on Acquisition |
SEARCH BY
Sebia is a provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic testing. Its systems analyse proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies. Sebia was founded in 1967 and is headquartered in Lisses, France.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Add-on Acquisition M&A Deals | 1 of 1 |
| Country: Germany M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 1 |
| Category | Private Equity Firm |
|---|---|
| Founded | 2005 |
| PE ASSETS | 6.0B USD |
| Size | Mega |
| Type | Sector Focused |
Water Street is a specialist private equity firm that targets investments in healthcare companies. Specific areas of interest within healthcare include diagnostic devices, medical products, pharmaceutical services, specialty distribution, specialty pharmaceuticals, and specialty services. Water Street targets non-core units of larger corporations and private middle-market companies. Transactions are typically valued between $50 and $500 million. Water Street does not invest in biotechnology, traditional healthcare facilities (hospitals, nursing homes) or early-stage companies without positive cash flow. Water Street was formed in 2005 and is based in Chicago, Illinois.
| DEAL STATS | # |
|---|---|
| Overall | 30 of 31 |
| Sector: Life Science M&A | 6 of 7 |
| Type: Add-on Acquisition M&A Deals | 18 of 19 |
| Country: Germany M&A | 1 of 1 |
| Year: 2021 M&A | 1 of 2 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-01-11 |
Medical Guardian
Philadelphia, Pennsylvania, United States Medical Guardian is a provider of senior health solutions. The company offers a full suite of connected care medical alert systems that empower older adults to live a life without limits. Medical Guardian provides nationwide support to more than 160,000 aging Americans who are ready to take on the next chapter of life while remaining safe in their own home. Whether it’s an in-home system, mobile device with GPS/Wi-Fi capabilities, or an all-in-one wearable medical alert smartwatch, Medical Guardian has the personal medical alert device to meet an array of needs and lifestyles. Medical Guardian was founded in 2005 and is based in Philadelphia, Pennsylvania. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-09-27 |
Custopharm
Carlsbad, California, United States Custopharm is a generic injectable drug services company. The company specializes in developing a range of generic injectable products, including those with complex formulations. Custopharm also offers regulatory consulting services to help customers with drafting and filing abbreviated new drug applications (ANDAs). Custopharm was formed in 2005 and is based in Carlsbad, California. |
Sell | $375M |
